[go: up one dir, main page]

BR9808810A - Processo para a sìntese de inibidores de redutase de ribonucleotìdeo 3-ap e 3-amp - Google Patents

Processo para a sìntese de inibidores de redutase de ribonucleotìdeo 3-ap e 3-amp

Info

Publication number
BR9808810A
BR9808810A BR9808810-6A BR9808810A BR9808810A BR 9808810 A BR9808810 A BR 9808810A BR 9808810 A BR9808810 A BR 9808810A BR 9808810 A BR9808810 A BR 9808810A
Authority
BR
Brazil
Prior art keywords
synthesis
reductase inhibitors
ribonucleotide reductase
thiosemicarbazone
carboxaldehyde
Prior art date
Application number
BR9808810-6A
Other languages
English (en)
Inventor
Chuan-Sherng Niu
Jun Li
Xiuyan Li
Terrence W Doyle
Shu-Hui Chen
Original Assignee
Vion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vion Pharmaceuticals Inc filed Critical Vion Pharmaceuticals Inc
Publication of BR9808810A publication Critical patent/BR9808810A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO PARA A SìNTESE DE INIBIDORES DE REDUTASE DE RIBONUCLEOTìDEO 3-AP e 3-AMP"<D>. A presente invenção refere-se a sínteses químicas eficientes, melhoradas, de tiossemicarbazona de 3-aminopiridina-2-carboxaldeído (3-AP) e tiossemicarbazona de 3-amino-4-metilpiridina-2-carboxaldeído (3-AMP).
BR9808810-6A 1997-05-15 1998-05-14 Processo para a sìntese de inibidores de redutase de ribonucleotìdeo 3-ap e 3-amp BR9808810A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/856,559 US5869676A (en) 1997-05-15 1997-05-15 Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP
PCT/US1998/009803 WO1998051670A1 (en) 1997-05-15 1998-05-14 Process for the synthesis of ribonucleotide reductase inhibitors 3-ap and 3-amp

Publications (1)

Publication Number Publication Date
BR9808810A true BR9808810A (pt) 2000-07-18

Family

ID=25323946

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808810-6A BR9808810A (pt) 1997-05-15 1998-05-14 Processo para a sìntese de inibidores de redutase de ribonucleotìdeo 3-ap e 3-amp

Country Status (10)

Country Link
US (1) US5869676A (pt)
EP (1) EP0984932A4 (pt)
JP (1) JP2001526665A (pt)
KR (1) KR20010012616A (pt)
CN (1) CN1117733C (pt)
AU (1) AU728165B2 (pt)
BR (1) BR9808810A (pt)
CA (1) CA2289970A1 (pt)
RU (1) RU2198875C2 (pt)
WO (1) WO1998051670A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911460B2 (en) * 2001-04-20 2005-06-28 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
US6951875B2 (en) 2001-10-29 2005-10-04 Hoffmann-La Roche Inc. Conjugated aromatic compounds with a pyridine substituent
CA2548491A1 (en) * 2003-12-08 2005-06-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Synergistic anti-cancer compositions
EP1744761A4 (en) * 2004-04-28 2010-01-13 Molecules For Health Inc METHOD FOR THE TREATMENT OR PREVENTION OF RESTENOSIS AND OTHER PROLIFERATIVE VASCULAR DISORDER
US9526707B2 (en) * 2007-08-13 2016-12-27 Howard L. Elford Methods for treating or preventing neuroinflammation or autoimmune diseases
MD3995C2 (ro) * 2009-05-11 2010-07-31 Государственный Университет Молд0 Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar
MD4126C1 (ro) * 2010-11-15 2012-04-30 Государственный Университет Молд0 N,N'-[4,4'-(perfluoro-1,4-fenilendioxi)-bis(4,1-fenilen)]-bis[2-(piridin-2-ilmetilen)hidrazincarbotioamidă] şi utilizarea ei în calitate de inhibitor al proliferării celulelor LNCaP ale cancerului prostatei
MD4132C1 (ro) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar
CN102627593A (zh) * 2012-02-23 2012-08-08 河南师范大学 具有抗癌活性的1，4-二羟基-2-甲酰基-9，10蒽醌缩氨硫脲新化合物及制备方法
US20140271812A1 (en) 2013-03-14 2014-09-18 Panacea Pharmaceuticals Treatment for chemotherapy-induced cognitive impairment
US20140287021A1 (en) 2013-03-21 2014-09-25 Panacea Pharmaceuticals Treatment of chemotherapy-induced peripheral neuropathy
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
CN112592330A (zh) * 2020-12-14 2021-04-02 陕西师范大学 一种2-醛基硫色酮类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229403A (en) * 1990-07-10 1993-07-20 Ishihara Sangyo Kaisha Ltd. Diaminotrifluoromethylpyridine derivatives and phospholipase A2 inhibitor containing them
TW299317B (pt) * 1993-03-12 1997-03-01 Chemie Linz Gmbh

Also Published As

Publication number Publication date
KR20010012616A (ko) 2001-02-26
US5869676A (en) 1999-02-09
EP0984932A4 (en) 2001-04-04
CA2289970A1 (en) 1998-11-19
WO1998051670A1 (en) 1998-11-19
EP0984932A1 (en) 2000-03-15
AU7571498A (en) 1998-12-08
CN1117733C (zh) 2003-08-13
JP2001526665A (ja) 2001-12-18
HK1025567A1 (en) 2000-11-17
AU728165B2 (en) 2001-01-04
CN1256688A (zh) 2000-06-14
RU2198875C2 (ru) 2003-02-20

Similar Documents

Publication Publication Date Title
BR9808810A (pt) Processo para a sìntese de inibidores de redutase de ribonucleotìdeo 3-ap e 3-amp
BR9608839A (pt) Processo para síntese assimétrica do composto quiral e do composto n-[4-metoxibenzil]-6cloro-2-[r-ciclopropiletinil-hidroxi-trifluorometil-metil anilina quiral e composto
BR9610110A (pt) Processo para diminuir a corrosividade de um cru corrosivo contendo ácido
NO20011351D0 (no) FremgangsmÕte for behandling av diabetes ved anvendelse av en AP2 inhibitor og kombinasjon derav
IL193244A0 (en) Amine derivatives useul for the synthesis of ceramide-like compounds and methods utilizing the same
BR0104896B1 (pt) processo para a sìntese de uréia.
ID21538A (id) Turunan anilida, produksi dan pemakaiannya
ES2193709T3 (es) Nuevos efectores de la dipeptidil-peptidasa iv.
BR9611499A (pt) Processo para a síntese em fase de gás eletroquímica direta de fosgênio
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
BR9809111B1 (pt) intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos.
DK0713533T3 (da) Biokatalytiske metoder til syntese og identifikation af biologisk aktive forbindelser
BR9603691A (pt) Processo para a produção de nitrilas saturadas por amoxidação de hidrocarbonetos e para a síntese de acetonitrila
DE59902179D1 (de) Elektrochemische synthese von perfluoralkylfluorophosphoranen
DE69912206D1 (de) Verbesserte Synthese von Haloformiminverbindungen
DE59803410D1 (de) Phenolsäureamide hydroxysubstituierter Benzylamine
BR9912010A (pt) Polimorfo de um produto farmacêutico
IT1275451B (it) Procedimento per la sintesi dell&#39;urea comprendente due separate zone di reazione
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
BR9610520A (pt) Processo para produção conjunta de amônia e metanol
EA199900790A1 (ru) Способы получения пестицидных промежуточных соединений
PT1066276E (pt) Processo para a sintese de inibidores de protease de hiv
NO975679L (no) Fremgangsmåte for fremstilling av N-monosubstituerte og N,N&#39;-disubstituerte, usymmetriske, cykliske ureaer
BR0202786B1 (pt) processo de sìntese de uréia.
BR9814774B1 (pt) processo para a preparação de (-)cis-3-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidi na e intermediários para sua preparação.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1914 DE 11/09/2007.